CVE-2026-80095: Microsoft Office SharePoint XSS privilege escalation

CVE-2026-80095 · Severity: critical · CVSS 9 · Published 2026-11-10

Microsoft SharePoint is a collaboration platform used by organizations to manage documents and team sites. An authorized attacker can inject malicious script into web pages viewed by other users, allowing them to steal administrator credentials or take control of the platform and its sensitive business documents.

Technologies: Microsoft Office SharePoint. Vendors: Microsoft.

Quick answers

Is CVE-2026-80095 exploited in the wild?
No. Junglewise Threat Intelligence has no report of CVE-2026-80095 being exploited in the wild.
How severe is CVE-2026-80095?
Critical severity, with a CVSS score of 9, published 10 November 2026.
Which products and versions are affected?
Microsoft Office SharePoint.
Is there a fix for CVE-2026-80095?
No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
How is CVE-2026-80095 attacked?
It is attacked over the network, in a web application.
Am I affected by CVE-2026-80095?
Check whether you run Microsoft Office SharePoint. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

Technical details

This is a cross-site scripting (XSS) vulnerability in the web page generation of Microsoft Office SharePoint that fails to properly neutralize user input. An authenticated attacker can inject malicious scripts that execute in the browser context of other users, leading to privilege escalation. The vulnerability requires network access and prior authentication to exploit.

Affected products

  • Microsoft Office SharePoint

Timeline

  • 2026-11-10: disclosed

References

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.